Our findings reinforce the growing recognition that NEXMIF variants contribute to a wide phenotypic spectrum, necessitating a high index of suspicion for genetic testing in patients presenting with neurodevelopmental disorders, particularly those with ASD and epilepsy. The gene discussed is NEXMIF; the disease is epilepsy.